Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Malinovschi, G. Johansson, P. Venge, H. Hedenström, C. Janson, K. Alving (Uppsala, Sweden). Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD. Eur Respir J 2013; 42: Suppl. 57, 719

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014 Exhaled bimarkers in exacerbation of COPD Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007 Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Effects of inhaled corticosteroids on breath condensate inflammatory markers in childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 41s Year: 2005 Effect of tiotropium on exhaled breath temperature in patients with COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled markers in the monitoring of airways inflammation in mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004 Prediction of CF exacerbations in children by exhaled inflammation markers Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Use of exhaled nitric oxide measurements to guide treatment in chronic asthma Source: Annual Congress 2006 - Scientific year in review Year: 2006 Exhaled nitric oxide in diagnosis and management of respiratory diseases Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Effects of exacerbations and seasonality on exhaled nitric oxide in COPD Source: Eur Respir J 2005; 26: 1009-1015 Year: 2005